Pre-clinical assessment of poly-arginine peptide R18D as a therapeutic to reduce central nervous system injury following neurotrauma

Project Details

StatusFinished
Effective start/end date1/07/1730/06/18

Funding

  • Neurotrauma Research Program (NRP): A$49,415.00
  • Neurotrauma Research Program (NRP): A$50,235.00